Company Search:
Advanced Search
Sponsored Links
Kyongbo Pharmaceutical Co Ltd Company Snapshot
Kyongbo Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kyongbo Pharmaceutical Co Ltd with three other companies in this sector in KOREA (SOUTH) : Kolon Life Science Incorporation (2019 sales of 148.54 billion Korean Won [US$126.41 million] of which 98% was Chemical), Kyungdong Pharm (176.50 billion Korean Won [US$150.20 million] of which 95% was Medicine), and DaehanPharmaceutical (168.76 billion Korean Won [US$143.62 million] ).

Sales Analysis. During the year ended December of 2019, sales at Kyongbo Pharmaceutical Co Ltd were 191.71 billion Korean Won (US$163.14 million). This is a decrease of 4.8% versus 2018, when the company's sales were 201.34 billion Korean Won . Contributing to the drop in overall sales was the 38.5% decline in Cefa Api, from 69.05 billion Korean Won to 42.49 billion Korean Won . There were also decreases in sales in Other Raw Material (down 4.6% to 27.54 billion Korean Won ) and Carcinostatis Substance Api (down 6.8% to 3.19 billion Korean Won ) and Kyongbo Cefaclor Cap (down 17.7% to 1.19 billion Korean Won ) . However, these declines were partially offset by the increase in sales of General Api (up 27.2% to 71.43 billion Korean Won ) and Other Finished Goods (up 7.0% to 40.29 billion Korean Won ) and Sojourn Inhalation Anesthetics (up 13.5% to 2.91 billion Korean Won ) and Rosueze Tab (up 22.1% to 2.66 billion Korean Won ) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kyongbo Pharmaceutical Co Ltd
  Stock Performance Chart for Kyongbo Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 10,250
(Figures in Korean Won )
1 Week -12.0%   13 Weeks -10.9%  
4 Weeks 9.4%   52 Weeks 23.8%  
Kyongbo Pharmaceutical Co Ltd Key Data:
  Ticker: 214390 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 191,706,189,111
(Year Ending Jan 2020).
Employees: 494
  Currency: Korean Won Market Cap: 245,045,315,000
  Fiscal Yr Ends: December Shares Outstanding: 23,906,860
  Share Type: Common Closely Held Shares: 15,145,081
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.